Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tumeurs solides
- Lymphomes non hodgkinien
- The 2 others...
- | Specialty :
- Thérapies Ciblées
Extract
A phase I/II, open-label, multi-center study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the Tor kinase inhibitor AZD8055 administered orally to patients with advanced solid tumours, lymphomas and endometrial carcinoma.
Scientific Abstract
en cours d'intégration;